ZNF654 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.766200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.566800E-01
Normal-vs-Stage2
4.128200E-01
Normal-vs-Stage3
3.716500E-02
Normal-vs-Stage4
6.926800E-01
Stage1-vs-Stage2
8.704600E-01
Stage1-vs-Stage3
8.535900E-02
Stage1-vs-Stage4
1.554430E-01
Stage2-vs-Stage3
9.039900E-02
Stage2-vs-Stage4
1.263200E-01
Stage3-vs-Stage4
1.976050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.501600E-01
Normal-vs-AfricanAmerican
7.112000E-01
Normal-vs-Asian
3.207200E-01
Caucasian-vs-AfricanAmerican
6.418200E-01
Caucasian-vs-Asian
6.063600E-01
AfricanAmerican-vs-Asian
5.629800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.429400E-01
Normal-vs-Female
4.415400E-01
Male-vs-Female
3.949600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.011600E-01
Normal-vs-Age(41-60Yrs)
8.008200E-01
Normal-vs-Age(61-80Yrs)
2.628000E-01
Normal-vs-Age(81-100Yrs)
4.284300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.471800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.138400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.642160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.560900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.677000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.138030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.625760E-01
Normal-vs-Daily Drinker
9.758300E-02
Normal-vs-Weekly Drinker
2.494400E-01
Normal-vs-Occasional Drinker
7.802000E-01
Normal-vs-Social Drinker
5.997400E-01
Non Drinker-vs-Daily Drinker
4.023800E-01
Non Drinker-vs-Weekly Drinker
9.444200E-01
Non Drinker-vs-Occasional Drinker
7.138300E-02
Non Drinker-vs-Social Drinker
1.663640E-01
Daily Drinker-vs-Weekly Drinker
5.654400E-01
Daily Drinker-vs-Occasional Drinker
2.620300E-02
Daily Drinker-vs-Social Drinker
5.935600E-02
Weekly Drinker-vs-Occasional Drinker
1.607610E-01
Weekly Drinker-vs-Social Drinker
2.662000E-01
Occasional Drinker-vs-Social Drinker
7.236600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.063590E-01
Normal-vs-Grade 2
1.401890E-02
Normal-vs-Grade 3
1.505560E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.840200E-02
Grade 1-vs-Grade 3
4.448400E-02
Grade 1-vs-Grade 4
1.063590E-01
Grade 2-vs-Grade 3
5.131800E-01
Grade 2-vs-Grade 4
1.401890E-02
Grade 3-vs-Grade 4
1.505560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.868150E-01
Normal-vs-NonDiabetic
3.282200E-01
Diabetic-vs-NonDiabetic
2.443400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.089600E-01
Normal-vs-NoPancreatitis
3.035200E-01
Pancreatitis-vs-NoPancreatitis
7.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.735600E-01
Normal-vs-N1
4.493400E-01
N0-vs-N1
1.722640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.233000E-01
Normal-vs-TP53-NonMutant
4.073600E-01
TP53-Mutant-vs-TP53-NonMutant
4.089200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
